Paraffin immunoreactivity of CD10, CDw75, and bcl-6 in follicle center cell lymphoma

被引:10
作者
Dunphy, CH [1 ]
Polski, JM [1 ]
Evans, HL [1 ]
Gardner, LJ [1 ]
机构
[1] St Louis Univ, Hlth Sci Ctr, Dept Pathol, Div Hematopathol, St Louis, MO 63104 USA
关键词
immunohistochemistry; CD10; CDw75; bcl-6; follicle center cell lymphoma;
D O I
10.3109/10428190109060349
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Follicle center cell lymphoma(FCCL) has the following immunophenotype(IP): sIg+, Pan B+, CD1O+/-, CD5-, CD23-/+, CD43-, CD11c-, CD25-. In addition, reactivities of a malignant lymphoma with CDw75(LN-1) and bcl-6 are considered indicators of FCCL. Bcl-6 expression is common in Grade 1 FCCL (100%) and rare in other indolent B-cell lymphomas(BCL). In contrast, bcl-2 expression is common in FCCL (80%) and in other BCL subtypes. Since no previous study has correlated paraffin immunoreactivity(PIR) of CD10, CDw75, and bcl-6 in FCCL (Grades 1-3), this is this study's purpose. Twenty-nine FCCL's were identified and reviewed (6, Grade 1; 10, Grade 2; 13, Grade 3) from the Division of Hematopathology, St. Louis University. The diagnoses were based on morphology and immunohistochemistry(IH)(21 cases) +/- the flow cytometric IP(14 cases). The paraffin blocks were stained for CD10 (Novacastra, Vector Laboratories, Burlingame, CA), CDw75 and bcl-6 (DAKO Corporation, Carpinteria, CA). Results showed that, CD10 by paraffin IH(PIH) was positive in 23 [18(strong); 3(moderate); 2(weak)] and negative in 6(3, Grade 2; 3, Grade 3). All CD10-cases were CDw75+; 4, bcl-6+. The two CD10-, bcl-6-cases were Grade 2. CDw75 was positive in 28 cases [16(strong); Il(moderate); 1(weak)] and negative in 1 (Grade 3; CD10+, bcl-2+, bcl-6+). Bcl-6 was positive in 26 [16(strong); 6(moderate); 4(weak)] and negative in 3(Grade 2's). Thus, the sensitivity of CD10, CDw75, and bcl-6 by PM for FCCL was 79%, 97%, and 90%, respectively. Of the three stains evaluated by PIH in FCCL, CDw75 was the most sensitive, closely followed by bcl-6. CD10 was least sensitive-79%. By combining these 3 stains, the sensitivity was 100%; thus, a combined approach is recommended.
引用
收藏
页码:585 / +
页数:12
相关论文
共 13 条
[1]  
CHAN JKC, 1995, AM J CLIN PATHOL, V103, P543
[2]   CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas [J].
Dogan, A ;
Bagdi, E ;
Munson, P ;
Isaacson, PG .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (06) :846-852
[3]  
Flenghi L, 1996, AM J PATHOL, V148, P1543
[4]  
Lai R, 1998, MODERN PATHOL, V11, P864
[5]  
MARDER RJ, 1985, LAB INVEST, V52, P497
[6]   EXPRESSION IN NON-HODGKINS LYMPHOMA OF THE BCL-2 PROTEIN ASSOCIATED WITH THE T(14-18) CHROMOSOMAL TRANSLOCATION [J].
NGAN, BY ;
CHENLEVY, Z ;
WEISS, LM ;
WARNKE, RA ;
CLEARY, ML .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (25) :1638-1644
[7]   BCL-6 GENE-PRODUCT, A 92-KD TO 98-KD NUCLEAR PHOSPHOPROTEIN, IS HIGHLY EXPRESSED IN GERMINAL CENTER B-CELLS AND THEIR NEOPLASTIC COUNTERPARTS [J].
ONIZUKA, T ;
MORIYAMA, M ;
YAMOCHI, T ;
KURODA, T ;
KAZAMA, A ;
KANAZAWA, N ;
SATO, K ;
KATO, T ;
OTA, H ;
MORI, S .
BLOOD, 1995, 86 (01) :28-37
[8]  
PEZZELLA F, 1990, AM J PATHOL, V137, P225
[9]  
Pittaluga S, 1996, J PATHOL, V179, P145
[10]  
Raible MD, 1999, AM J CLIN PATHOL, V112, P101